annual cash & cash equivalents:
$525.50M+$109.70M(+26.38%)Summary
- As of today (May 29, 2025), ZBH annual cash & cash equivalents is $525.50 million, with the most recent change of +$109.70 million (+26.38%) on December 31, 2024.
- During the last 3 years, ZBH annual cash & cash equivalents has risen by +$147.40 million (+38.98%).
- ZBH annual cash & cash equivalents is now -63.99% below its all-time high of $1.46 billion, reached on December 31, 2015.
Performance
ZBH Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.38B+$859.00M(+163.46%)Summary
- As of today (May 29, 2025), ZBH quarterly cash & cash equivalents is $1.38 billion, with the most recent change of +$859.00 million (+163.46%) on March 31, 2025.
- Over the past year, ZBH quarterly cash & cash equivalents has increased by +$991.50 million (+252.29%).
- ZBH quarterly cash & cash equivalents is now -84.26% below its all-time high of $8.79 billion, reached on March 31, 2015.
Performance
ZBH quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ZBH Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.4% | +252.3% |
| 3 y3 years | +39.0% | +217.7% |
| 5 y5 years | -14.9% | -43.1% |
ZBH Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.9% | at high | +374.0% |
| 5 y | 5-year | -34.5% | +39.9% | -43.1% | +374.0% |
| alltime | all time | -64.0% | >+9999.0% | -84.3% | +8718.5% |
ZBH Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.38B(+163.5%) |
| Dec 2024 | $525.50M(+26.4%) | $525.50M(-7.6%) |
| Sep 2024 | - | $569.00M(+35.4%) |
| Jun 2024 | - | $420.10M(+6.9%) |
| Mar 2024 | - | $393.00M(-5.5%) |
| Dec 2023 | $415.80M(+10.7%) | $415.80M(+42.3%) |
| Sep 2023 | - | $292.10M(-8.7%) |
| Jun 2023 | - | $319.80M(-3.1%) |
| Mar 2023 | - | $330.20M(-12.1%) |
| Dec 2022 | $375.70M(-0.6%) | $375.70M(-31.1%) |
| Sep 2022 | - | $545.40M(+41.1%) |
| Jun 2022 | - | $386.40M(-11.3%) |
| Mar 2022 | - | $435.80M(+15.3%) |
| Dec 2021 | $378.10M(-52.9%) | $378.10M(-58.9%) |
| Sep 2021 | - | $919.60M(-11.8%) |
| Jun 2021 | - | $1.04B(+43.9%) |
| Mar 2021 | - | $724.30M(-9.7%) |
| Dec 2020 | $802.10M(+29.8%) | $802.10M(-17.1%) |
| Sep 2020 | - | $967.30M(+35.6%) |
| Jun 2020 | - | $713.40M(-70.7%) |
| Mar 2020 | - | $2.43B(+293.9%) |
| Dec 2019 | $617.90M(+13.8%) | $617.90M(+20.6%) |
| Sep 2019 | - | $512.50M(+27.1%) |
| Jun 2019 | - | $403.10M(-31.3%) |
| Mar 2019 | - | $586.80M(+8.1%) |
| Dec 2018 | $542.80M(+3.5%) | $542.80M(+3.5%) |
| Sep 2018 | - | $524.60M(+9.0%) |
| Jun 2018 | - | $481.20M(-72.7%) |
| Mar 2018 | - | $1.77B(+236.7%) |
| Dec 2017 | $524.40M(-17.3%) | $524.40M(+9.1%) |
| Sep 2017 | - | $480.80M(+6.8%) |
| Jun 2017 | - | $450.00M(-56.7%) |
| Mar 2017 | - | $1.04B(+63.9%) |
| Dec 2016 | $634.10M(-56.5%) | $634.10M(+33.4%) |
| Sep 2016 | - | $475.30M(-51.3%) |
| Jun 2016 | - | $976.30M(-2.1%) |
| Mar 2016 | - | $996.80M(-31.7%) |
| Dec 2015 | $1.46B(+34.7%) | $1.46B(-0.5%) |
| Sep 2015 | - | $1.47B(+3.0%) |
| Jun 2015 | - | $1.42B(-83.8%) |
| Mar 2015 | - | $8.79B(+711.7%) |
| Dec 2014 | $1.08B(+0.2%) | $1.08B(+12.0%) |
| Sep 2014 | - | $967.30M(-0.1%) |
| Jun 2014 | - | $968.70M(+9.7%) |
| Mar 2014 | - | $882.70M(-18.3%) |
| Dec 2013 | $1.08B | $1.08B(+17.8%) |
| Sep 2013 | - | $917.40M(+29.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $709.90M(+8.1%) |
| Mar 2013 | - | $657.00M(-25.7%) |
| Dec 2012 | $884.30M(+15.1%) | $884.30M(+10.3%) |
| Sep 2012 | - | $801.50M(+23.1%) |
| Jun 2012 | - | $651.00M(-3.4%) |
| Mar 2012 | - | $674.00M(-12.3%) |
| Dec 2011 | $768.30M(+14.9%) | $768.30M(+38.9%) |
| Sep 2011 | - | $553.00M(-11.4%) |
| Jun 2011 | - | $624.10M(+8.4%) |
| Mar 2011 | - | $575.60M(-13.9%) |
| Dec 2010 | $668.90M(-3.3%) | $668.90M(-29.9%) |
| Jun 2010 | - | $953.70M(+16.1%) |
| Mar 2010 | - | $821.20M(+18.7%) |
| Dec 2009 | $691.70M(+225.4%) | $691.70M(+57.3%) |
| Sep 2009 | - | $439.70M(+58.5%) |
| Jun 2009 | - | $277.50M(+30.4%) |
| Mar 2009 | - | $212.80M(+0.1%) |
| Dec 2008 | $212.60M(-54.2%) | $212.60M(-60.8%) |
| Sep 2008 | - | $542.40M(+39.8%) |
| Jun 2008 | - | $388.10M(-18.5%) |
| Mar 2008 | - | $476.00M(+2.6%) |
| Dec 2007 | $463.90M(+74.6%) | $463.90M(+48.2%) |
| Sep 2007 | - | $313.00M(-12.7%) |
| Jun 2007 | - | $358.70M(+10.0%) |
| Mar 2007 | - | $326.00M(+22.7%) |
| Dec 2006 | $265.70M(+13.9%) | $265.70M(-3.6%) |
| Sep 2006 | - | $275.60M(-17.9%) |
| Jun 2006 | - | $335.80M(-16.8%) |
| Mar 2006 | - | $403.80M(+73.2%) |
| Dec 2005 | $233.20M(+50.8%) | $233.20M(+154.0%) |
| Sep 2005 | - | $91.80M(+16.5%) |
| Jun 2005 | - | $78.80M(+38.2%) |
| Mar 2005 | - | $57.00M(-63.1%) |
| Dec 2004 | $154.60M(+99.5%) | $154.60M(+241.3%) |
| Sep 2004 | - | $45.30M(-41.1%) |
| Jun 2004 | - | $76.90M(-29.3%) |
| Mar 2004 | - | $108.70M(+40.3%) |
| Dec 2003 | $77.50M(+393.6%) | $77.50M(-56.2%) |
| Sep 2003 | - | $177.00M(+53.9%) |
| Jun 2003 | - | $115.00M(+244.3%) |
| Mar 2003 | - | $33.40M(+112.7%) |
| Dec 2002 | $15.70M(-14.7%) | $15.70M(-24.5%) |
| Sep 2002 | - | $20.80M(-21.2%) |
| Jun 2002 | - | $26.40M(+26.9%) |
| Mar 2002 | - | $20.80M(+13.0%) |
| Dec 2001 | $18.40M(>+9900.0%) | $18.40M(-21.4%) |
| Sep 2001 | - | $23.40M |
| Dec 2000 | $0.00 | - |
FAQ
- What is Zimmer Biomet Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Zimmer Biomet Holdings?
- What is Zimmer Biomet Holdings annual cash & cash equivalents year-on-year change?
- What is Zimmer Biomet Holdings quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Zimmer Biomet Holdings?
- What is Zimmer Biomet Holdings quarterly cash & cash equivalents year-on-year change?
What is Zimmer Biomet Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of ZBH is $525.50M
What is the all time high annual cash & cash equivalents for Zimmer Biomet Holdings?
Zimmer Biomet Holdings all-time high annual cash & cash equivalents is $1.46B
What is Zimmer Biomet Holdings annual cash & cash equivalents year-on-year change?
Over the past year, ZBH annual cash & cash equivalents has changed by +$109.70M (+26.38%)
What is Zimmer Biomet Holdings quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ZBH is $1.38B
What is the all time high quarterly cash & cash equivalents for Zimmer Biomet Holdings?
Zimmer Biomet Holdings all-time high quarterly cash & cash equivalents is $8.79B
What is Zimmer Biomet Holdings quarterly cash & cash equivalents year-on-year change?
Over the past year, ZBH quarterly cash & cash equivalents has changed by +$991.50M (+252.29%)